By Counterforce Health Team in Tremfya (guselkumab) —

Do You Qualify for Tremfya (Guselkumab) Coverage by UnitedHealthcare in Illinois? Decision Tree & Next Steps

Answer Box: Quick Qualification Check

Most Illinois patients qualify for Tremfya (guselkumab) coverage through UnitedHealthcare if they have moderate-to-severe plaque psoriasis (PASI ≥10), psoriatic arthritis, or inflammatory bowel disease AND have failed required step therapy (typically TNF inhibitors like Humira plus other agents).

Fastest path: Have your dermatologist or GI specialist submit prior authorization through the UHC Provider Portal with documented therapy failures, TB screening results, and severity scores. If denied, Illinois law guarantees external review within 4 months. Start today: Gather your treatment history and schedule TB screening if not done within 12 months.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Document Checklist
  4. If "Possibly Eligible": Tests to Request
  5. If "Not Yet": Alternatives and Exceptions
  6. If Denied: Illinois Appeal Path
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & Fixes
  9. FAQ: UnitedHealthcare Tremfya Coverage

How to Use This Decision Tree

This guide walks you through UnitedHealthcare's specific requirements for Tremfya (guselkumab) coverage in Illinois. Work through each section in order—most patients will find their path in the first two sections. If you're already denied, skip to the appeals section.

Before starting: Have your insurance card, recent lab results, and a list of all psoriasis, psoriatic arthritis, or IBD treatments you've tried (including dates and outcomes).

Eligibility Triage: Do You Qualify?

Step 1: Confirm Your Diagnosis

You need one of these confirmed diagnoses:

  • Moderate-to-severe plaque psoriasis (ICD-10 L40.0)
  • Active psoriatic arthritis
  • Moderately to severely active ulcerative colitis or Crohn's disease

Step 2: Check Disease Severity

For Plaque Psoriasis:

  • PASI score ≥10 OR
  • ≥10% body surface area affected OR
  • Dermatologist assessment of moderate-to-severe disease requiring systemic therapy

For Psoriatic Arthritis:

  • Active joint symptoms despite conventional treatment
  • Rheumatologist or dermatologist confirmation

For IBD (UC/Crohn's):

  • Moderate-to-severe active disease
  • Gastroenterologist assessment

Step 3: Review Required Prior Therapies

UnitedHealthcare requires documented failure of:

Condition Required Step Therapy
Plaque Psoriasis Phototherapy OR methotrexate (3+ months) PLUS one biologic (e.g., Skyrizi, Stelara, Cosentyx)
Psoriatic Arthritis Methotrexate (3+ months at max dose) PLUS one TNF inhibitor or other biologic
UC/Crohn's Disease Conventional therapy (e.g., corticosteroids) PLUS one TNF inhibitor OR ustekinumab/Skyrizi

Step 4: TB Screening Status

Required within 12 months:

  • QuantiFERON-TB Gold test OR tuberculin skin test
  • Chest X-ray if positive
  • Treatment of latent TB before starting Tremfya (if applicable)
Note: If you're currently on Tremfya through samples or manufacturer assistance, you may bypass some step therapy requirements, but UnitedHealthcare will verify your treatment history.

If "Likely Eligible": Document Checklist

Required Documentation

Clinical Records:

  • Diagnosis confirmation with ICD-10 codes
  • PASI score documentation (for psoriasis) or disease activity measures
  • Complete prior therapy history with dates, doses, duration, and outcomes
  • TB screening results (QuantiFERON + chest X-ray if positive)
  • Prescriber specialty confirmation (dermatologist for psoriasis/PsA, GI for IBD)

Insurance Information:

  • Current UnitedHealthcare member ID
  • Plan type and pharmacy benefit details
  • Prior authorization form completion

Submission Process

  1. Provider submits PA via UHC Provider Portal or fax to 1-844-403-1029
  2. Standard review time: 15 business days
  3. Approval duration: 12 months if criteria met
  4. Track status: Provider portal or call member services

When coverage needs help navigating complex insurance requirements, Counterforce Health specializes in turning denials into targeted, evidence-backed appeals by analyzing your specific plan's policies and crafting point-by-point rebuttals that speak directly to your insurer's criteria.

If "Possibly Eligible": Tests to Request

Missing Documentation to Gather

If you lack severity documentation:

  • Request PASI scoring from dermatologist
  • Document percentage body surface area affected
  • Get formal assessment of disease impact on quality of life

If prior therapy history is incomplete:

  • Contact previous providers for treatment records
  • Document specific reasons for therapy failures (ineffectiveness vs. intolerance)
  • Include dates, doses, and duration for each treatment

If TB screening is outdated:

  • Schedule QuantiFERON-TB Gold test
  • Complete chest X-ray
  • Allow 1-2 weeks for results before PA submission

Timeline to Re-apply

  • Gather missing docs: 2-4 weeks
  • Complete new PA: Submit within 30 days of obtaining all requirements
  • Expedited review: Available if treatment delay poses health risks

If "Not Yet": Alternatives and Exceptions

Alternative Coverage Paths

Manufacturer Support:

  • Janssen CarePath enrollment for coverage assistance
  • Copay savings programs (if not Medicare/Medicaid)
  • Patient assistance programs for uninsured/underinsured

Medical Exception Requests:

  • Document contraindications to required step therapies
  • Provide evidence of severe adverse reactions
  • Include specialist recommendations for Tremfya as first-line therapy

Alternative Treatments to Discuss:

  • Other IL-23 inhibitors (Skyrizi/risankizumab)
  • IL-17 inhibitors (Cosentyx, Taltz)
  • JAK inhibitors (Rinvoq for IBD)
  • TNF inhibitors if not yet tried

If Denied: Illinois Appeal Path

Internal Appeals (First Step)

Timeline: File within 180 days of denial notice How to file:

  • UHC Provider Portal appeals section
  • Fax with additional documentation
  • Include denial letter and new clinical evidence

Peer-to-Peer Review:

  • Request during appeal process
  • Prepare clinical rationale with specialist
  • Schedule via provider portal or phone number on denial letter

External Review (Illinois Rights)

Illinois residents have strong appeal rights under state law:

Step Timeline Action Required
File Request Within 4 months of final denial Submit Illinois DOI External Review Form
Eligibility Review 5 business days IDOI confirms eligibility
IRO Assignment 1 business day Independent physician reviewer assigned
Final Decision 45 days (72 hours if expedited) Binding decision on coverage

Illinois Consumer Resources:

Coverage Requirements at a Glance

Requirement Plaque Psoriasis Psoriatic Arthritis IBD (UC/Crohn's) Source
Prior Auth Required Required Required UHC Policy
Severity PASI ≥10 or BSA ≥10% Active disease Moderate-severe active UHC PA Form
Step Therapy Phototherapy + 1 systemic/biologic MTX + 1 TNF/biologic Conventional + 1 TNF/biologic UHC PA Criteria
TB Screening Required within 12 months Required within 12 months Required within 12 months FDA Label
Prescriber Dermatologist preferred Rheum/Derm Gastroenterologist UHC Guidelines
Approval Duration 12 months 12 months 12 months UHC Policy

Common Denial Reasons & Fixes

Denial Reason How to Overturn Documents Needed
"Insufficient severity" Submit PASI ≥10 documentation or BSA assessment Dermatologist severity scoring
"Step therapy not met" Document specific therapy failures with dates/outcomes Prior therapy records, failure reasons
"Not medically necessary" Provide specialist rationale and guideline citations Medical necessity letter, treatment guidelines
"Missing TB screening" Complete required testing QuantiFERON results, chest X-ray
"Wrong prescriber specialty" Transfer prescription to appropriate specialist Dermatologist/GI specialist prescription
From our advocates: "We've seen UnitedHealthcare approvals increase significantly when providers include specific PASI scores, exact dates of prior therapy trials, and clear documentation of why each previous treatment failed. The key is showing you've genuinely tried their preferred options first."

FAQ: UnitedHealthcare Tremfya Coverage

How long does UnitedHealthcare PA take in Illinois? Standard review is 15 business days. Expedited review (for urgent cases) is typically completed within 72 hours.

What if Tremfya is non-formulary on my plan? Most UnitedHealthcare plans cover Tremfya with prior authorization. Check your plan's formulary or call member services to confirm coverage.

Can I request an expedited appeal in Illinois? Yes, if delay would seriously jeopardize your health. Include physician certification of urgency with your appeal.

Does step therapy apply if I failed treatments outside Illinois? Yes, UnitedHealthcare accepts documented therapy failures from any state. Ensure you have complete records from previous providers.

What's the difference between internal and external appeals? Internal appeals are reviewed by UnitedHealthcare. External appeals are reviewed by independent physicians through the Illinois Department of Insurance and are binding on the insurer.

How much will Tremfya cost with UnitedHealthcare? Costs vary by plan. Many patients pay $5-50/month with manufacturer copay assistance. Check your plan's specialty pharmacy tier and copay structure.

Can I use Janssen CarePath with UnitedHealthcare? Yes, CarePath can help with prior authorization support and may provide temporary medication while coverage is pending (verify eligibility requirements).

What happens if my appeal is denied? You can file for external review through the Illinois Department of Insurance within 4 months. This independent review is binding and free to patients.

For complex cases requiring detailed appeals strategy, Counterforce Health helps patients and providers build compelling cases by analyzing specific plan policies and crafting evidence-backed rebuttals tailored to each insurer's requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always verify current requirements with your insurer and consult your healthcare provider for medical decisions. For assistance with insurance appeals in Illinois, contact the Illinois Department of Insurance at (877) 527-9431.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.